Uwell Biopharma, Inc. (TPEX:7902)
Taiwan · Delayed Price · Currency is TWD 40.10
+0.30 (0.75%)
At close: Mar 27, 2026
Uwell Biopharma Revenue
Uwell Biopharma had revenue of 450.00K TWD in the twelve months ending June 30, 2025. In the year 2024, Uwell Biopharma had annual revenue of 450.00K.
Revenue
450.00K
Revenue Growth
n/a
P/S Ratio
17,822.22
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 450.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| WITS Corp. | 11.60B |
| Shin Ruenn development Co., LTD | 9.45B |
| ThinTech Materials Technology | 5.71B |
| IBASE Technology | 5.36B |
| Dimerco Data System | 3.41B |
| Sunfun Info | 2.63B |
| Rayzher Industrial | 2.56B |
| Bioteque | 2.14B |